PP

Priyanka Palacharla

Director Director DIN 02925766
DIN 02925766 First appointment Jan 2010 Primary industry FMCG
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2010
Shareholding value •••• Premium profile

About Priyanka Palacharla

Data last updated:

Priyanka Palacharla was a Director at Farmax India Limited (2014–2023) and Director at Msr India Limited (2010–2017). The companies operate in FMCG and Food and Beverages.

DIN 02925766
Primary Designation Director
Industry FMCG
First Appointment 04 Jan 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Farmax India Limited L27109TG1995PLC022190
Director30 Sep 20141995₹4.43 Cr (FY 2017)Active
Msr India Limited L15122TG2002PLC039031
Director04 Jan 20102002₹29.66 Cr (FY 2021)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Farmax India Limited
Msr India Limited
Premium access

Shareholding and investment profile for Priyanka Palacharla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Palacharla

Priyanka Palacharla was first appointed on 04 Jan 2010 as Director at Msr India Limited. The most recent appointment on record is 30 Sep 2014 at Farmax India Limited.

Priyanka Palacharla held 2 earlier board appointments: Farmax India Limited (Director, 30 Sep 2014 to 30 Jun 2023); Msr India Limited (Director, 04 Jan 2010 to 17 Feb 2017).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available